Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 8, 2024
Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL StudyBinayak Sinha, Samit GhosalExpert Review of Clinical Pharmacology|April 24, 2020
Translating the statistical benefits of SGLT-2 inhibitors on cardio-renal outcomes into clinical practiceSamit Ghosal, Binayak SinhaFrontiers in Endocrinology|March 10, 2022
A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary SyndromeBinayak Sinha, Samit GhosalDiabetes & Metabolic Syndrome|March 23, 2013
Pioglitazone--do we really need it to manage type 2 diabetes?Binayak Sinha, Samit GhosalDiabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 25, 2022
Assessing the Effects of Modern Renoprotective Agents in Preventing Progression of Renal Composite Outcomes in Patients with Type 2 Diabetes: A Network Meta-analysisSamit Ghosal, Binayak SinhaScientific Reports|September 26, 2020
Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trialsBinayak Sinha, Samit GhosalDiabetes Research and Clinical Practice|February 23, 2019
Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failureBinayak Sinha, Samit GhosalDiabetes & Metabolic Syndrome|January 3, 2017
Secondary cvd prevention-Lipid modification strategies: A critical analysisSamit Ghosal, Binayak SinhaJournal of Diabetes Research|December 10, 2015
Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOSSamit Ghosal, Binayak SinhaCurrent Diabetes Reviews|October 26, 2019
Is it Worth CANVASing for CREDENCE? A Benefit-risk AnalysisBinayak Sinha, Samit GhosalPageof 6